drugset / Trial / NCT02264197

Investigation of Pharmacokinetics of BIBX 245 CL and Safety in Healthy Subjects

NCT02264197 ↗

Phase 1 Completed 8 enrolled Boehringer Ingelheim
RandomizedCrossoverOpen-labelTreatment

Summary

Aim of this trial is to investigate the single dose pharmacokinetics and the effect of food on single dose of 160 mg 245 CL (two 80 mg tablets) as well as its safety

Timeline

Start
1998-05
Primary completion
1998-06
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject BIBX 245 CL Unknown 160 mg Oral

Indications

No indication recorded.